Categories Consumer, Earnings

Pier 1 Imports’ Q2 results miss expectations

Pier 1 Imports Inc. (NYSE: PIR) missed revenue forecasts and reported a wider-than-expected loss for the second quarter of 2020, sending shares falling over 6% in after-market hours on Wednesday. The consensus estimate was for a loss of $15.88 per share on revenue of $315.2 million.  

Net sales fell 14.3% year-over-year to $304.6 million. Comparable sales fell 12.6%, reflecting lower average customer spend, mainly due to merchandise mix changes, as well as lower store traffic.  

Net loss was $100.6 million, or $24.29 per share, compared to $51.1 million, or $12.68 per share, a year earlier.

Gross profit fell to $50.8 million, or 16.7% of net sales, from $93.5 million, or 26.3% of net sales, in the prior-year period. The decline mainly reflects increased clearance activity, as well as 240 basis points of deleverage on occupancy costs.

Cheryl Bachelder, Interim CEO, said, “The organization continues to make progress against our fiscal 2020 action plan, and we remain on track to achieve benefits of $100-110 million this year, as previously outlined. While we anticipate that our merchandising and marketing initiatives will start to gain traction during the second half, we expect a gradual recovery and believe we’ll be positioned to demonstrate year-over-year improvement in company comparable sales and gross margin rate beginning in the fourth quarter.”

Also read: Pier 1 Imports Q2 2020 Earnings Preview

At quarter-end, inventory totaled $328.6 million, down 15% from a year ago. The company operated 951 stores at the end of the quarter, a decrease of 38 from the same period last year.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top